Sutro Biopharma Inc (STRO)
3.23
-0.05
(-1.52%)
USD |
NASDAQ |
Jun 21, 16:00
3.30
+0.07
(+2.17%)
After-Hours: 20:00
Sutro Biopharma Accounts Receivable (Quarterly): 31.30M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 31.30M |
December 31, 2023 | 36.08M |
September 30, 2023 | 16.63M |
June 30, 2023 | 9.999M |
March 31, 2023 | 9.873M |
December 31, 2022 | 7.122M |
September 30, 2022 | 11.24M |
June 30, 2022 | 97.67M |
March 31, 2022 | 11.69M |
December 31, 2021 | 12.45M |
September 30, 2021 | 12.33M |
June 30, 2021 | 9.16M |
March 31, 2021 | 7.227M |
Date | Value |
---|---|
December 31, 2020 | 5.559M |
September 30, 2020 | 7.483M |
June 30, 2020 | 5.102M |
March 31, 2020 | 9.079M |
December 31, 2019 | 6.298M |
September 30, 2019 | 7.531M |
June 30, 2019 | 6.50M |
March 31, 2019 | 3.338M |
December 31, 2018 | 2.489M |
September 30, 2018 | 2.443M |
June 30, 2018 | 3.184M |
December 31, 2017 | 1.624M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
5.102M
Minimum
Jun 2020
97.67M
Maximum
Jun 2022
16.02M
Average
9.516M
Median
Accounts Receivable (Quarterly) Benchmarks
AnaptysBio Inc | 7.089M |
ABVC BioPharma Inc | 0.0015M |
Reviva Pharmaceuticals Holdings Inc | -- |
Flora Growth Corp | 2.278M |
Journey Medical Corp | 9.799M |